A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs.

[1]  B. Sakmann,et al.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches , 1981, Pflügers Archiv.

[2]  A H Glassman,et al.  Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. , 2001, The American journal of psychiatry.

[3]  K. Wasan,et al.  Plasma protein and lipoprotein distribution of clozapine. , 2001, The American journal of psychiatry.

[4]  D J Triggle,et al.  Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG. , 2001, Molecular pharmacology.

[5]  Jun Chen,et al.  A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Sanders,et al.  Cardiovascular Adverse Effects of Antipsychotic Drugs , 2000, Drug safety.

[7]  D. Rampe,et al.  High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide. , 2000, European journal of pharmacology.

[8]  E. Richelson.  Receptor pharmacology of neuroleptics: relation to clinical effects. , 1999, The Journal of clinical psychiatry.

[9]  C. January,et al.  Block of HERG Potassium Channels by the Antihistamine Astemizole and its Metabolites Desmethylastemizole and Norastemizole , 1999, Journal of cardiovascular electrophysiology.

[10]  P. Young,et al.  The use of atypical antipsychotics in the management of schizophrenia. , 1999, British journal of clinical pharmacology.

[11]  D. Rampe,et al.  The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG. , 1998, The Journal of pharmacology and experimental therapeutics.

[12]  J. Arnt,et al.  Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence , 1998, Neuropsychopharmacology.

[13]  A. Brown,et al.  A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG , 1997, FEBS letters.

[14]  Qiuming Gong,et al.  Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride. , 1997, American journal of physiology. Heart and circulatory physiology.

[15]  H. Hartman,et al.  Iloperidone binding to human and rat dopamine and 5-HT receptors. , 1996, European journal of pharmacology.

[16]  M. Sanguinetti,et al.  Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel , 1996, Nature.

[17]  Jacques Barhanin,et al.  KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current , 1996, Nature.

[18]  A. Brown,et al.  HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. , 1996, Circulation.

[19]  S. Krähenbühl,et al.  Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication. , 1995, The American journal of the medical sciences.

[20]  M. Sanguinetti,et al.  A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.

[21]  D. Zipes,et al.  Torsades de pointes and proarrhythmia , 1993, The Lancet.

[22]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.